Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non‐Hodgkin lymphoma-Reference-Cited by-同舟云学术

Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non‐Hodgkin lymphoma

Published:2019-06-20 Issue:10 Volume:8 Page:4688-4698
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Wu Ke¹,Sun Xiao‐Qing¹,Wang Cai‐Qin¹,Gao Tian‐Xiao¹,Sun Peng¹,Wang Yu¹,Jiang Wen‐Qi¹,Li Zhi‐Ming¹^ORCID,Huang Jia‐Jia¹

Affiliation:

1. Department of Medical Oncology, Sun Yat‐sen University Cancer Center, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2364

Reference39 articles.

1. Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment

2. Synergistic antitumor effects of combination treatment with metronomic doxorubicin and VEGF-targeting RNAi nanoparticles

3. Adaptive Therapy

4. The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma

5. A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules;Cancer Letters;2024-06

2. Metronomic chemotherapy in cancer treatment: new wine in an old bottle;Theranostics;2024

3. Cellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies;Biochemical Pharmacology;2022-05

4. Metronomic chemotherapy regimens and targeted therapies in non-Hodgkin lymphoma: The best of two worlds;Cancer Letters;2022-01

5. Evaluation of solid tumor response to sequential treatment cycles via a new computational hybrid approach;Scientific Reports;2021-11-02